FGF23 induces left ventricular hypertrophy

The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study

(2013) Benjamin D. Parker   ANNALS OF INTERNAL MEDICINE

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

(2011) Tamara Isakova   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

(2011) Tamara Isakova et al.   KIDNEY INTERNATIONAL

Cardioprotective effect of calcineurin inhibition in an animal model of renal disease

(2010) Giovana S. Di Marco et al.   EUROPEAN HEART JOURNAL

Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease

(2010) M. Wolf   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease

(2010) M. C. Hu et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

(2010) Hisashi Hasegawa et al.   KIDNEY INTERNATIONAL

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?

(2009) R. B. Oliveira et al.   Clinical Journal of the American Society of Nephrology

Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

(2009) Takashi Shimada et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Stimulus specific changes of energy metabolism in hypertrophied heart

(2009) S. Rimbaud et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease

(2009) H. Galitzer et al.   KIDNEY INTERNATIONAL

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients

(2009) G. Jean et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets

(2008) Anthony J. Muslin   CLINICAL SCIENCE

Overexpression of Fibroblast Growth Factor 23 Suppresses Osteoblast Differentiation and Matrix Mineralization In Vitro

(2008) Hua Wang et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation

(2008) Norbert Frey et al.   JOURNAL OF CLINICAL INVESTIGATION

The Klotho gene family as a regulator of endocrine fibroblast growth factors

(2008) Hiroshi Kurosu et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

(2008) Christian Faul et al.   NATURE MEDICINE

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE